Search

Filters
Clear All
  • 17
  • 51
  • 645

Phase

  • 13
  • 16
  • 56
  • 8
  • 81
  • 5
  • 525
  • 631
  • 285
  • 699
  • 14

Found 713 in-health trials

A listing of in-health medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

B
Bharathi Muthusamy
18 years - 100 years
All genders
This study investigates the stigma experienced by patients with lung cancer and other tobacco-related cancers, such as pancreatic adenocarcinoma, renal cell carcinoma, and urothelial carcinoma. A stigma is a mark of disgrace associated with a particular condition. The purpose of this study is to understand how stigma affects patients with …
G
Greg Durm, MD
18 years - 100 years
All genders
Phase 3
This study investigates the effectiveness and safety of an investigational medication compared to the investigator's choice of monotherapy treatment in patients with head and neck squamous cell carcinoma (HNSCC) that is incurable, metastatic, or recurrent. HNSCC is a type of cancer that occurs in the squamous cells lining the head …
M
Michael W. Sim, MD
18 years - 100 years
All genders
This study investigates a new approach for treating HPV-positive oropharyngeal squamous cell carcinoma (OPSCC). The purpose of this study is to see if reducing the intensity of treatment, based on levels of ctHPVDNA (pieces of cancer DNA in blood samples), can be as effective as the standard treatment. OPSCC is …
J
Jessica Parker Metter
18 years - 100 years
All genders
Phase 3
What is the purpose of this study?This phase III trial compares the effect of olaparib for one year versus two years, with or without bevacizumab, for the treatment of BRCA 1/2 mutated or homologous recombination deficient stage III or IV ovarian cancer. Olaparib is a polyadenosine 5'-diphosphoribose polymerase (PARP) enzyme …
K
Kathy Miller, MD
18 years - 100 years
All genders
Phase 3
This study investigates the effects of different durations of HER2-targeted therapy in patients with early-stage HER2-positive breast cancer. HER2-positive breast cancer is a type of cancer where a protein called HER2 is found on the surface of the cancer cells. This protein can make cancer cells grow faster. The purpose …
T
Tarah Ballinger, MD
18 years - 100 years
All genders
Phase 3
This study investigates an investigational medication combined with other treatments for adults with advanced breast cancer that is hormone receptor-positive (HR+) and human epidermal growth factor receptor 2-negative (HER2-). Participants must have a specific gene change called a PIK3CA mutation and their cancer must have spread to other parts of …
M
Mohammad Al-Haddad, MD
18 years or above
All genders
What is the purpose of this study?The purpose of having a database is to collect data related to endoscopic procedures performed by Indiana University physicians specifically for the treatment of gastroparesis. This data will be used for research purposes only to determine the clinical impact of endoscopic treatments on gastroparesis. …
 Healthy Females Needed To Help Develop A Vaccine for Chlamydia (IMPACT Study)
S
Stephen Jordan
18 years - 40 years
Accepts healthy volunteer
Female
Chlamydia trachomatis (CT) is the most reported bacterial sexually transmitted infection (STI) in the United States. Untreated chlamydia infection in women can result in pelvic inflammatory disease, infertility, and/or ectopic pregnancy. Although chlamydia rates are at an all-time high, no vaccine is available because we don't yet understand how immunity to …
M
Mythily Srinivasan
18 years - 100 years
All genders
This study is being conducted to help determine whether specific proteins and other markers in saliva can predict development of taste changes, gum health and diabetes in previously coronavirus-2 infected patients with persistent symptoms or long COVID-19. 
M
Mateusz Opyrchal, MD, PhD
18 years or above
All genders
Observational
What is the purpose of this study?The purpose of this study is to create models out of tissue samples and treat those models with the same immunotherapy treatment the patient will be receiving, in order to validatehis process and to predict responses to therapies and use it to choose the …
611 - 620 of 713